ReviewBritish journal of cancer2022

Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity.

Zhangchi Dongye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.